The global Endoscopic Submucosal Dissection (ESD) Market is gaining momentum as healthcare providers increasingly adopt minimally invasive technologies for the treatment of early gastrointestinal cancers. “According to a recent study by SNS Insider, the global Endoscopic Submucosal Dissection Market size valued at USD 390.88 million in 2025, is anticipated to grow to USD 668.32 million by 2035, registering a CAGR of 5.51% over the 2026–2035 forecast period.” Growing investments in advanced endoscopy systems, greater physician expertise, and the expansion of cancer screening initiatives are creating favorable conditions for sustained market growth across developed and emerging healthcare markets.
Global hospital facilities are beginning to gravitate toward less-invasive techniques that minimize stay times in hospitals, speed up recovery periods, and increase success rates. The constant advancement in the fields of endoscopic visualization, surgical equipment, and guiding technologies is enabling doctors to execute advanced gastrointestinal interventions with more certainty. This trend is promoting the adoption of ESD in regions other than Asia.
To Get Detailed Insights on the Endoscopic Submucosal Dissection Market – Request a Sample Report
Advanced Endoscopy Technologies Transform Clinical Practice
There is huge investment in the development of GI diagnostics, driven by the need to detect diseases earlier and reduce the invasiveness of treatments. Artificial intelligence in recognizing lesions, robotic endoscopy, and better visualization techniques are increasing the precision of the procedure and assisting doctors to locate lesions that can be targeted using endoscopy.
At the same time, the expansion of endoscopist training programs and the use of simulation in educating endoscopists are widening the number of qualified endoscopists in the world. This is motivating the use of ESD worldwide.
Key Market Findings Highlight Expanding Clinical Adoption
By product, ESD knives accounted for approximately 33.47% of market revenue in 2025, reflecting their essential role in endoscopic procedures. Meanwhile, injection agents are projected to register the fastest growth, expanding at a CAGR of 6.82% through 2035. Gastroscopes and colonoscopes represented approximately 26.73% of total market revenue.
By indication, stomach cancer remained the largest application segment with approximately 38.14% market share in 2025, while the colon cancer segment is expected to record the fastest growth at a 6.24% CAGR during the forecast period. Esophageal cancer accounted for approximately 21.38% of global demand.
Based on technology, conventional ESD maintained market leadership with approximately 57.63% revenue share in 2025. However, underwater ESD is forecast to expand at the fastest pace, recording a 7.46% CAGR, while hybrid ESD contributed approximately 19.24% of market revenue.
By end use, hospitals dominated the market with approximately 61.82% share in 2025 due to comprehensive treatment infrastructure and multidisciplinary expertise. Ambulatory surgical centers are expected to witness the strongest growth, advancing at a 7.18% CAGR through 2035, while specialty clinics accounted for approximately 12.47% of the market.
Innovation Strengthens Precision and Clinical Efficiency
The technological revolution is also affecting competition as companies develop next generation platforms for endoscopy, aimed at improving surgical accuracy and physicians' workflow. High-resolution imaging, assistance from AI in assessing lesions, robotically guided navigation, and better tissue visualization are helping achieve a higher level of confidence and lower the probability of complications.
Manufacturers have also introduced highly sophisticated dissection tools and techniques for injections that enhance safety in performing GI interventions. This will make ESD even more popular as clinicians look for an efficient means of avoiding surgery.
Regional Markets Continue to Expand Worldwide
The Asia Pacific region held the largest market share, representing 46.72% of total global revenue in 2025 and is forecasted to remain the fastest-growing region with a CAGR of 7.18% till 2035. Clinical expertise, reimbursement systems, and cancer screening will be driving regional dominance.
North America held a revenue share of 36.84% of total global revenue in 2025 owing to advancements in healthcare infrastructure and physician training. The United States endometrial cancer treatment market held a valuation of USD 144.63 million in 2025 and is forecasted to reach USD 248.52 million by 2035 at a CAGR of 5.57%.
Europe region captured a market revenue share of 11.63% of total revenue in 2025 on account of clinical adoption of guidelines and expanded reimbursement landscape. On the other hand, Latin America and Middle East and Africa regions are gaining momentum through investments in endoscopy and cancer diagnostics.
Leading Companies Focus on Next-Generation Endoscopy Solutions
Competition remains driven by continuous innovation, physician education, and expanding product portfolios. Leading companies operating in the global Endoscopic Submucosal Dissection Market include Olympus Corporation, FUJIFILM Holdings Corporation, Boston Scientific Corporation, Medtronic plc, Hoya Corporation (Pentax Medical), Karl Storz SE & Co. KG, Cook Medical LLC, Micro-Tech Endoscopy, Erbe Elektromedizin GmbH, Sumitomo Bakelite Co., Ltd., Medi-Globe GmbH, CONMED Corporation, Ovesco Endoscopy AG, Kaneka Corporation, Endo-Flex GmbH, Aohua Endoscopy Co., Ltd., STERIS plc, Nanjing Micro-Tech Co., Ltd., Hobbs Medical Inc., and Richard Wolf GmbH.
An SNS Insider analyst Parry Kardani commented, "Growing emphasis on early gastrointestinal cancer diagnosis, combined with rapid advances in AI-enabled imaging and minimally invasive endoscopic technologies, is accelerating the global adoption of endoscopic submucosal dissection. Companies delivering innovative visualization systems, precision instruments, and physician training support will remain well positioned to capitalize on future market expansion.
About the Author
Get in touch
